Koelis

Koelis develops advanced medical devices focused on improving the diagnosis and treatment of prostate cancer. Its flagship product, the KOELIS Trinity® system, enables highly accurate MRI/ultrasound image fusion-guided biopsies using proprietary real-time tracking software. The company’s technologies are used globally to enhance diagnostic confidence and enable minimally invasive “focal” therapies as alternatives to radical treatments. Clinical results show improved accuracy in targeted biopsies with over a million patients benefiting from their systems worldwide. Ongoing multicenter registries are evaluating new applications such as microwave ablation guided by their platform.